Jane Kasozi Namagga1, Godfrey Zari Rukundo2, Vallence Niyonzima3, Joachim Voss4. 1. Department of Nursing, Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda. jkasozi@must.ac.ug. 2. Department of Psychiatry, Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda. 3. Department of Nursing, Faculty of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda. 4. Frances Payne Bolton School of Nursing, Case Western Reserve University, Cleveland, OH, 44106, USA.
Abstract
BACKGROUND: HIV-Associated Neurocognitive Disorder (HAND remains a pronounced consequence of HIV/AIDS despite improved life expectancies. This is often associated with several dysfunctions such as decrease of attention, mood alterations and psychomotor disturbances. Many factors, including age, gender, employment status, and psychiatric disorders, have been associated with HAND. Among the associated psychiatric disorders, depression is often more prevalent. It can influence not only quality of life, relationships and employment but also adherence to medical care. We assessed the prevalence of depression and its association with HAND among people living with HIV in rural Southwestern Uganda. METHODS: This was a cross-sectional study that used Beck Depression Inventory-1 and International HIV Dementia Scale to assess depression and HAND respectively. We defined depression with a score of > 10 and HAND with a cutoff score of ≤10. We conducted data analysis using STATA version 12, and Pearson Chi-square test and logistic regression to determine associations between depression and HAND. The level of statistical significance was set at p ≤ 0.05. Ethical approval and administrative clearance were obtained from relevant bodies. RESULTS: Of the 393 participants assessed for depression and HAND, 27% had depression and 58.3% screened positive for HAND. All levels of depression were more prevalent among female participants. We found a significant association between depression and HIV associated neurocognitive disorders (χ2 (3) = 9.0538 p = 0.029). CONCLUSION: Our findings confirmed a high prevalence of depression in individuals with HAND which is a major component of the disease burden.
BACKGROUND:HIV-Associated Neurocognitive Disorder (HAND remains a pronounced consequence of HIV/AIDS despite improved life expectancies. This is often associated with several dysfunctions such as decrease of attention, mood alterations and psychomotor disturbances. Many factors, including age, gender, employment status, and psychiatric disorders, have been associated with HAND. Among the associated psychiatric disorders, depression is often more prevalent. It can influence not only quality of life, relationships and employment but also adherence to medical care. We assessed the prevalence of depression and its association with HAND among people living with HIV in rural Southwestern Uganda. METHODS: This was a cross-sectional study that used Beck Depression Inventory-1 and International HIV Dementia Scale to assess depression and HAND respectively. We defined depression with a score of > 10 and HAND with a cutoff score of ≤10. We conducted data analysis using STATA version 12, and Pearson Chi-square test and logistic regression to determine associations between depression and HAND. The level of statistical significance was set at p ≤ 0.05. Ethical approval and administrative clearance were obtained from relevant bodies. RESULTS: Of the 393 participants assessed for depression and HAND, 27% had depression and 58.3% screened positive for HAND. All levels of depression were more prevalent among female participants. We found a significant association between depression and HIV associated neurocognitive disorders (χ2 (3) = 9.0538 p = 0.029). CONCLUSION: Our findings confirmed a high prevalence of depression in individuals with HAND which is a major component of the disease burden.
Authors: Justin C McArthur; Norman Haughey; Suzanne Gartner; Kathy Conant; Carlos Pardo; Avi Nath; Ned Sacktor Journal: J Neurovirol Date: 2003-04 Impact factor: 2.643
Authors: A Antinori; G Arendt; J T Becker; B J Brew; D A Byrd; M Cherner; D B Clifford; P Cinque; L G Epstein; K Goodkin; M Gisslen; I Grant; R K Heaton; J Joseph; K Marder; C M Marra; J C McArthur; M Nunn; R W Price; L Pulliam; K R Robertson; N Sacktor; V Valcour; V E Wojna Journal: Neurology Date: 2007-10-03 Impact factor: 9.910
Authors: Emily B Wroe; Bethany L Hedt-Gauthier; Molly F Franke; Sabin Nsanzimana; Jean Bosco Turinimana; Peter Drobac Journal: Int J STD AIDS Date: 2014-05-14 Impact factor: 1.359
Authors: J Hampton Atkinson; Robert K Heaton; Thomas L Patterson; Tanya Wolfson; Reena Deutsch; Stephen J Brown; J Summers; A Sciolla; R Gutierrez; Ronald J Ellis; Ian Abramson; John R Hesselink; J Allen McCutchan; Igor Grant Journal: J Affect Disord Date: 2007-11-28 Impact factor: 4.839
Authors: Bin Tang; A C Collier; S Morgello; D Cookson; N Sacktor; Ronald J Ellis; Christina M Marra; David B Clifford; Benjamin B Gelman; Jessica Robinson-Papp; J Allen McCutchan; Scott Letendre; Robert K Heaton; Igor Grant Journal: Brain Behav Immun Health Date: 2022-03-10